Zillow A股 ZG 深 沪
交易中 06-30 10:41:24 美东时间
30.345
-1.045
-3.33%
华盛通- 最 高30.64
- 今 开30.54
- 成交量 14.15万股
- 最 低 29.86
- 昨 收 31.39
- 总市值 694.30万
- 52周最高 90.22
- 市盈率 静 335.30
- 换手率 0.06%
- 52周最低 29.03
- 委 比 77.58%
- 总股本 0.00亿
- 历史最高 212.40
- 量 比 0.62
- 振 幅 2.48%
- 历史最低 -29.156
- 每 手 1
- 风险率 16.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Adobe惨遭18家大行下调目标价！CFRA首予SpaceX(SPCX)"卖出"评级，目标价115美元
今日重点评级关注：Piper Sandler：维持Tenax Therapeutics"超配"评级，目标价从20美元升至50美元；Tigress Financial：维持优步"买入"评级，目标价从110美元升至115美元
06-15 08:32
Goldman Sachs Maintains Neutral on Zillow Group, Lowers Price Target to $40
Goldman Sachs analyst Mike Burton maintains Zillow Group (NASDAQ:ZG) with a Neutral and lowers the price target from $53 to $40.
06-13 01:30
美股夜盘 | Redwire Corp涨8.84%，Rocket Lab涨8.12%
Redwire Corp涨8.84%；Rocket Lab涨8.12%；NEBIUS涨7.33%
06-12 13:01
美股夜盘 | HR布洛克服务涨11.98%，Redwire Corp涨7.72%
HR布洛克服务涨11.98%；Redwire Corp涨7.72%；AST SPACEMOBILE涨6.87%
06-12 09:01
Google's Nationwide Expansion Into Home Listings Shakes Real Estate Incumbents
Google parent company Alphabet Inc (NASDAQ:GOOGL) (NASDAQ:GOOG) officially announced on Thursday the nationwide rollout of its Enhanced Local Services Ads for Home Listings across all 50 U.S. states. Here is what investors need to know about the launch. Alphabet stock is trading at elevated levels. ...
06-12 04:00
美股大行评级 | 高盛上调美光科技目标价从400美元升至900美元；斯马克、Cloudflare获多家公司上调目标价
今日重点评级关注：Ascendiant Capital：维持NextTrip"买入"评级，目标价从7美元升至7.5美元；Maxim Group：维持Zevra Therapeutics"买入"评级，目标价从25美元升至35美元
06-11 09:55
Midwest Real Estate Data Announces Potential Disruption To Listing Data Feeds To Zillow Group
Midwest Real Estate Data (MRED) announces that it will suspend property listing data feeds to Zillow Group websites, including Zillow.com and Trulia.com, unless Zillow cures its violation of its license agreements and
05-19 01:10
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
